http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cef8d520f63de16ecfe8ebca8f66bd98
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Buzdar |
| name | Aman U. Buzdar Aman U Buzdar |
| given-name | Aman U. Aman U |
| organization-name | From the Department of Breast Medical Oncology, Department of Surgical Oncology, Department of Pathology, Department of Diagnostic Radiology, and Department of Biostatistics at The University of Texas M.D. Anderson Cancer Center, Houston, TX. Department of Breast Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, TX, USA. 3University of Texas M.D. Anderson Cancer Center; From the Departments of Pathology, Surgery, and Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Nuvera Biosciences Inc, Woburn, MA Affiliations of authors: Departments of Clinical Cancer Prevention (AMB), Breast Medical Oncology (GNH, S-WK, CAS-M, BA, AUB, DJB, VV, FJE), Division of Quantitative Sciences (KRB), Department of Epidemiology (MB), The University of Texas M.D. Anderson Cancer Center, Houston, TX From the Departments of Breast Medical Oncology, Surgical Oncology, and Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Departments of Surgical Oncology, Biomathematics, Breast Medical Oncology, Pathology, and Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Departments of Breast Medical Oncology, Biostatistics and Applied Mathematics, Radiation Oncology, Surgical Oncology, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Oncology and Hematology, University of Modena e Reggio Emilia, Modena, Italy Min Yi, Elizabeth A. Mittendorf, Janice N. Cormier, Thomas A. Buchholz, Karl Bilimoria, Aysegul A. Sahin, Gabriel N. Hortobagyi, Ana Gonzalez-Angulo, Aman U. Buzdar, Jaime R. Crow, Henry M. Kuerer, and Kelly K. Hunt, The University of Texas MD Anderson Cancer Center; and Sheng Luo, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX. The University of Texas, M.D. Anderson Cancer Center, Houston, TX From the Departments of Breast Medical Oncology, Epidemiology, and Clinical Cancer Prevention and Division of Quantitative Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX Department of Breast Oncology, M.D. Anderson Cancer Center, Houston, Texas From The University of Texas M.D. Anderson Cancer Center, Houston, TX; and Brown University, Providence, RI From the Departments of Biostatistics and Applied Mathematics, Pathology, Breast Medical Oncology and Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Breast Cancer Unit and Unité Propre de l'Enseignement Supérieur; Equipe d'Accueil 3535 of the Institut Gustave Roussy, Villejuif, France; Albany Medical College, Albany NY; Departamento de Medicina Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú a Departments of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA. abuzdar@mdanderson.org Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Clinical Cancer Prevention, and 4Cytopathology, University of Texas MD Anderson Cancer Center, Houston, Texas a Departments of Breast Medical Oncology, Houston, Texas, USA Authors' Affiliations: Departments of 1Surgical Oncology, 2Pathology, 3Breast Medical Oncology, and 4Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; and 5Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain Department of Breast, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. From the University of Texas M.D. Anderson Cancer Center, Houston, TX. Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. abuzdar@mdanderson.org University of Texas M. D. Anderson Cancer Center, Houston, Texas From the Departments of Breast Medical Oncology and Quantitative Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and the Department of Medical Oncology, Dubai Hospital, United Arab Emirates University of Texas M. D. Anderson Cancer Center, Houston, Texas;3 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Authors' Affiliation: Departments of Breast Medical Oncology, Biostatistics and Applied Math, Surgical Oncology, Pathology, Cardiology, and Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, TX The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA University of Texas M.D. Anderson Cancer Center, Houston, Texas Office of Vice President for Clinical Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Department of Breast Oncology MD Anderson Cancer Center Houston Texas USA From the University of Texas M.D. Anderson Cancer Center, Houston, Texas. From the Departments of Surgical Oncology, Bioinformatics and Computational Biology, Breast Medical Oncology, Radiation Oncology, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Surgery, Northwestern University Feinberg School of Medicine; and Robert H. Lurie Comprehensive Cancer Center, Chicago, IL Jack Cuzick, Silvia Pineda, and Christopher Wale, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Mitch Dowsett, Janine Salter, Emma Quinn, and Lila Zabaglo, Royal Marsden Hospital, London; Elizabeth Mallon, Western Infirmary, North Glasgow University Hospital, Glasgow; Andrew R. Green and Ian O. Ellis, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals National Health Services Trust, City Hospital,... All authors, The University of Texas MD Anderson Cancer Center, Houston, TX. UT MD Anderson Cancer Center, Houston, TX, United States. From the Department of Medicine/Oncology, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, Dana-Farber Cancer Institute, Boston, MA; Department of Surgery, Emory University School of Medicine, Atlanta, GA; Departments of Breast Medical Oncology and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy; German Breast Group, Neu-Isenburg/University Womens... Authors' Affiliations: 1Division of Medical Oncology, 2Department of Health Sciences Research, and 3Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; 4Department of Breast Oncology, M.D. Anderson Cancer Center, Houston, Texas; 5Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York; 6Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona; 7Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida; 8Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana; and 9Taylor Technology, Inc., Princeton, New Jersey MD Anderson Cancer Center, Houston, TX From the Kidwai Memorial Institute of Oncology, Karnataka, Bangalore, India; Eli Lilly and Co, Indianapolis, IN; and The University of Texas M.D. Anderson Cancer Center, Houston, TX Department of Breast Oncology (A.U.B.), M.D. Anderson Cancer Center, Houston, Texas 77030; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Department of Breast and Gynecologic Medical Oncology The University of Texas M.D. Anderson Cancer Center 1515 Holcombe Boulevard 77030 Houston Texas USA The University of Texas M.D. Anderson Cancer Center, Houston, TX 5Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Office of Vice Provost for Clinical and Interdisciplinary Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the Departments of Breast Medical Oncology, Biostatistics, Surgical Oncology, Pathology, Cardiology, and Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX From the Departments of Radiation Oncology, Biomathematics, Breast Medical Oncology, and Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. From The University of Texas MD Anderson Cancer Center, Houston, TX; Northwestern University Feinberg School of Medicine, Chicago, IL; and University of Michigan, Ann Arbor, MI. The University of Texas M. D. Anderson Cancer Center, Houston, Texas Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA From the Departments of Breast Medical Oncology, Biostatistics and Applied Mathematics, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Breast Cancer Unit and UPRES EA, Institut Gustave Roussy, Villejuif, France; and Departments of Gynecologic Oncology and Breast Cancer Surgery (DA), Hotel-Dieu, Beirut, Lebanon. From the Departments of Radiation OncologyBiomathematics, Medical Oncology, and Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Departments of Breast Medical Oncology, Radiation Oncology, Surgery, and Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, TX, USA. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Centre, 1515 Holcombe Blvd, Box 424, Houston, TX 77030, USA. abuzdar@mdanderson.org From The University of Texas M.D. Anderson Cancer Center, Houston, TX W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People’s Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn,... Department of Breast Medical Oncology, Box 56, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030. Authors' Affiliations: 1Mayo Clinic College of Medicine, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3University of Oslo, Oslo, Norway; 4Keck School of Medicine, University of Southern California, Los Angeles, California; 5National Cancer Institute of Canada (NCIC) Clinical Trials Group, Queen's University, Kingston, Ontario, Canada; and 6Massachusetts General Hospital Cancer Center, Boston, Massachusetts From the University of Texas M.D. Anderson Cancer Center, Houston, TX; and The Liposome Company, Inc, Princeton, NJ. 1The University of Texas MD Anderson Cancer Center, Houston, Texas and Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX From the Departments of Breast Medical Oncology and Surgical Oncology, University of Texas M.D. Anderson Cancer Center; Department of Obstetrics and Gynecology, Baylor College of Medicine; and Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center, Houston, TX. 2The University of Texas M.D. Anderson Cancer Center, Houston, Texas Medicine, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX From the Departments of Surgical Oncology, Pathology, Breast Medical Oncology, and Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Physician Reliance Network (PRN) Research, Baylor-Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, and M.D. Anderson Cancer Center, Houston, TX; Harper Hospital, Detroit, MI; Massachusetts General Hospital, Boston, MA; Cancer Center, North Miami Beach, FL; and Hoffman-LaRoche, Inc, Nutley, NJ. From the Departments of Breast Medical Oncology and Quantitative Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Department of Medical Oncology, Dubai Hospital, Dubai, United Arab Emirates. Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Medical Breast Service, Houston, Texas 1Breast Medical Oncology, Departments of 4Breast Medical Oncology, From the Departments of Radiation Oncology, Biomathematics, Surgical Oncology, Breast Medical Oncology, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA |
Incoming Links
Total number of triples: 427.